<!DOCTYPE html>
<html lang="en">
    <head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <meta http-equiv="Content-Style-Type" content="text/css" />
        <title>ASA CT : Webinars</title>
        <style type="text/css">code{white-space: pre;}</style>
        <meta name="viewport" content="width=device-width, initial-scale=1">

        <link rel="stylesheet" href="normalize.css">
        <link rel="stylesheet" href="skeleton.css">
        <link rel="stylesheet" href="custom.css">
        <!-- <link href="//fonts.googleapis.com/css?family=Raleway:400,300,600" rel="stylesheet" type="text/css"> -->
    </head>
    <body>
        <div class="container">

	    <div class="bbox">

	        <div class="row header">
		    <div class="twelve columns">
		        <!-- width:height::866:406 -->
		        <a href="https://www.amstat.org/" style="border: none;">
			    <img src="asa.png" width="160" height="75"></a>
			    <br />
		            The American Statistical Association
		            <h1>
			        <a href="index.html" style="text-decoration: none">
			            Connecticut Chapter</a>
		            </h1>

		    </div>
	        </div> <!-- .row -->

	        <div class="row nav twelve columns">
		    <div class="nav">
		        <a href="index.html">Home</a> |
		        <a href="officers.html">Officers</a> |
                        <a href="media/CTASAconstitution-July2007_Final.pdf">Constitution</a> |
		        <a href="events.html">Chapter Events</a> |
		        <a href="webinars.html">Webinars</a> |
                        <a href="newsletter.html">Newsletter</a> |
		        <a href="contact.html">Contact</a>
		    </div>
	        </div>


	        <div class="row" style="margin-top: 5%">

		    <div class="twelve columns main">
		        <!-- <h3>Webinars</h3> -->
                        		        <h1 id="asa-bi-webinars">ASA-BI Webinars</h1>
<ul>
<li>“<a href="#webinar1">Bayesian designs in oncology clinical trials</a>”, Dr. Lili Zhao (July 25, 2017)</li>
<li>“<a href="#webinar2">How the ICH E9 addendum around estimands may impact our clinical trials</a>”, Dr. Frank Bretz (August 17, 2017)</li>
<li>“<a href="#webinar3">Impact of model complexity on operating characteristics of adaptive dose-finding methods</a>”, Dr. Alexia Iasonos (September 11th, 2017)</li>
<li>“<a href="#webinar4">Phase I trials design with dose expansion cohort</a>”, Dr. Jincheng Shen (October 17th, 2017)</li>
<li>“<a href="#webinar5">Blinded ongoing aggregate safety evaluation (Blinded-OASE)</a>”, Dr. Greg Ball and Dr. William Wang (November 8th, 2017)</li>
<li>“<a href="#webinar6">Assessing covariate effects using Jeffrey’s-type prior in the Cox model in the presence of a monotone partial likelihood</a>”, Dr. Jing Wu (December 6th, 2017)</li>
<li>“<a href="#webinar7">Dose-escalation trials without monotonicity assumption: A weighted differential entropy approach</a>”, Dr. Thomas Jaki (February 27th, 2018)</li>
<li>“<a href="#webinar8">EMPA-REG Outcome® - A Cardiovascular Outcome Trial designed according to the FDA Guidance ‘Diabetes Mellitus– Evaluating Cardiovascular Risk in New Anti-diabetic Therapies to Treat Type 2 Diabetes’</a>”, Dr. Stefan Hantel (April 5th, 2018)</li>
<li>“<a href="#webinar9">A practical design for a dual-agent dose-escalation trial that incorporates pharmacokinetic data</a>”, Dr. Amy Cotterill (April 24th, 2018)</li>
</ul>
<h2 id="webinar1">ASA-BI Statistics Webinar Series # 1</h2>
<ul>
<li><em>Topic:</em> Bayesian designs in oncology clinical trials</li>
<li><em>Speaker:</em> Dr. Lili Zhao, Research Assistant Professor, Biostatistics Department, University of Michigan, USA</li>
<li><a href="media/webinars-asa-bi/Webinar-series-flyer---1---Lili-Zhao.pdf">Abstract</a></li>
<li><em>Date:</em> July 25th, 2017</li>
<li><em>Time:</em> 9:00-10:00 EST (New York), including 10-minute Q&amp;A</li>
<li><a href="media/webinars-asa-bi/presentation-webinar1-Lili-Zhao.pdf">Slides</a></li>
</ul>
<h2 id="webinar2">ASA-BI Statistics Webinar Series # 2</h2>
<ul>
<li><em>Topic:</em> How the ICH E9 addendum around estimands may impact our clinical trials</li>
<li><em>Speaker:</em> Dr. Frank Bretz, Global Head, Statistical Methodology and Consulting Group, Novartis, Switzerland</li>
<li><a href="media/webinars-asa-bi/Webinar-series-flyer---2---Frank-Bretz.pdf">Abstract</a></li>
<li><em>Date:</em> August 17th, 2017</li>
<li><em>Time:</em> 9:00-10:00 EST (New York), including 10-minute Q&amp;A</li>
<li><a href="media/webinars-asa-bi/presentation-webinar2-Frank-Bretz.pdf">Slides</a></li>
</ul>
<h2 id="webinar3">ASA-BI Statistics Webinar Series # 3</h2>
<ul>
<li><em>Topic:</em> Impact of model complexity on operating characteristics of adaptive dose-finding methods</li>
<li>Speakers: Dr. Alexia Iasonos, Associate Attending Biostatistician, Memorial Sloan Kettering Cancer Center and Dr. Nolan Wages, Associate Professor, University of Virginia, USA</li>
<li><a href="media/webinars-asa-bi/Webinar-series-flyer---3---Alexia-Iasonos---Nolan-Wages.pdf">Abstract</a></li>
<li><em>Date:</em> September 11th, 2017</li>
<li><em>Time:</em> 9:00-10:00 EST (New York), including 10-minute Q&amp;A</li>
<li><a href="media/webinars-asa-bi/presentation-webinar3-Alxia-Iasonos-and-Nolan-Wages.pdf">Slides</a></li>
</ul>
<h2 id="webinar4">ASA-BI Statistics Webinar Series # 4</h2>
<ul>
<li><em>Topic:</em> Phase I trials design with dose expansion cohort</li>
<li><em>Speaker:</em> Dr. Jincheng Shen, Assistant Professor, Department of Population Health Sciences, University of Utah, USA</li>
<li><a href="media/webinars-asa-bi/Webinar-series-flyer---4---Jincheng-Shen.pdf">Abstract</a></li>
<li><em>Date:</em> October 17th, 2017</li>
<li><em>Time:</em> 9:00-10:00 EST (New York), including 10-minute Q&amp;A</li>
<li><em>Slides:</em> Upon request</li>
</ul>
<h2 id="webinar5">ASA-BI Statistics Webinar Series # 5</h2>
<ul>
<li><em>Topic:</em> Blinded ongoing aggregate safety evaluation (Blinded-OASE)</li>
<li><em>Speaker:</em> Dr. Greg Ball, Principal Statistician and Dr. William (Bill) Wang, Executive Director, Merck Pharmaceuticals, Inc.<br />
</li>
<li><a href="media/webinars-asa-bi/Webinar-series-flyer---5---Greg-Ball---William-Wang.pdf">Abstract</a></li>
<li><em>Date:</em> November 8th, 2017</li>
<li><em>Time:</em> 9:00-10:00 EST (New York), including 10-minute Q&amp;A</li>
<li><a href="media/webinars-asa-bi/presentation-webinar5-Greg-Ball-and-William-Wang.pdf">Slides</a></li>
</ul>
<h2 id="webinar6">ASA-BI Statistics Webinar Series # 6</h2>
<ul>
<li><em>Topic:</em> Assessing covariate effects using Jeffrey’s-type prior in the Cox model in the presence of a monotone partial likelihood</li>
<li><em>Speaker:</em> Dr. Jing Wu, Assistant Professor, University of Rhode Island, USA</li>
<li><a href="media/webinars-asa-bi/Webinar-series-flyer---6---Jing-Wu.pdf">Abstract</a></li>
<li><em>Date:</em> December 6th, 2017</li>
<li><em>Time:</em> 9:00-10:00 EST (New York), including 10-minute Q&amp;A</li>
<li><a href="media/webinars-asa-bi/presentation-webinar6-Jing-Wu.pdf">Slides</a></li>
</ul>
<h2 id="webinar7">ASA-BI Statistics Webinar Series # 7</h2>
<ul>
<li><em>Topic:</em> Dose-escalation trials without monotonicity assumption: A weighted differential entropy approach</li>
<li><em>Speaker:</em> Dr. Thomas Jaki, Professor of Statistics, Lancaster University, UK</li>
<li><a href="media/webinars-asa-bi/Webinar-series-flyer---7---Thomas-Jaki.pdf">Abstract</a></li>
<li><em>Date:</em> February 27th, 2018</li>
<li><em>Time:</em> 9:00-10:00 EST (New York), including 10-minute Q&amp;A</li>
<li><a href="media/webinars-asa-bi/presentation-webinar7-Thomas-Jaki.pdf">Slides</a></li>
</ul>
<h2 id="webinar8">ASA-BI Statistics Webinar Series # 8</h2>
<ul>
<li><em>Topic:</em> EMPA-REG Outcome® - A Cardiovascular Outcome Trial designed according to the FDA Guidance “Diabetes Mellitus– Evaluating Cardiovascular Risk in New Anti-diabetic Therapies to Treat Type 2 Diabetes”</li>
<li><em>Speaker:</em> Dr. Stefan Hantel, Therapeutic Area Statistician, Boehringer Ingelheim, Germany</li>
<li><a href="media/webinars-asa-bi/Webinar-series-flyer---8---Stefan-Hantel.pdf">Abstract</a></li>
<li><em>Date:</em> April 5th, 2018</li>
<li><em>Time:</em> 9:00-10:00 EST (New York), including 10-minute Q&amp;A</li>
</ul>
<h2 id="webinar9">ASA-BI Statistics Webinar Series # 9</h2>
<ul>
<li><em>Topic:</em> A practical design for a dual-agent dose-escalation trial that incorporates pharmacokinetic data</li>
<li><em>Speaker:</em> Dr. Amy Cotterill, Senior Statistician, Cancer Research UK Clinical Trials Unit, University of Birmingham, UK</li>
<li><a href="media/webinars-asa-bi/Webinar-series-flyer---9---AmyCotterill.pdf">Abstract</a></li>
<li><em>Date:</em> April 24th, 2018</li>
<li><em>Time:</em> 9:00-10:00 EST (New York), including 10-minute Q&amp;A</li>
</ul>
		    </div>

	        </div> <!-- .row -->
	    </div> <!-- .bbox -->

        </div> <!-- .container -->
  </body>
</html>
